EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

DECORIN , a triceps‐derived myokine, protects sorted β‐cells and human islets against chronic inflammation associated with type 2 diabetes

Allan Langlois, Julien Cherfan, Emmanuelle Meugnier, Ahmad Rida, Caroline Arous, Claude Peronet, Harzo Hamdard, Bader Zarrouki, Bernhard Wehrle-Haller, Michel Pinget, Siobhan M Craige, Karim Bouzakri iD

Acta Physiologica · 2025-02 · 241 (2)

DOI: 10.1111/apha.14267 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Physiologica, online erschienen am 22.01.2025. Verfasst von Allan Langlois und 11 weiteren Autor:innen. Beteiligte Einrichtung: UR Diabète et Thérapeutiques, Centre européen d'étude du Diabète, Université de Strasbourg, Strasbourg, France. Hauptthemen laut MEDLINE: Decorin, Diabetes Mellitus, Type 2, Insulin-Secreting Cells, Inflammation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Centre Europeen d'Etude du Diabete.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Pancreatic β‐cells are susceptible to inflammation, leading to decreased insulin production/secretion and cell death. Previously, we have identified a novel triceps‐derived myokine, DECORIN, which plays a pivotal role in skeletal muscle‐to‐pancreas interorgan communication. However, whether DECORIN can directly impact β‐cell function and susceptibility to inflammation remains unexplored.

Methods

The effect of DECORIN was assessed in sorted human and rat β‐cell and human islets from healthy and type 2 diabetes (T2D) donors. We assessed glucose‐stimulated insulin secretion (GSIS) and cytokine‐mediated cell death. We then challenged sorted β‐cells and human islets with inflammatory cytokines commonly associated with diabetes, such as tumor necrosis factor‐α (TNF‐α) alone or in combination with interleukin1‐β (IL1‐β) and interferon‐γ (cytomix).

Results

DECORIN enhanced cell spreading and the localization of phosphorylated FAK at adhesions, promoting GSIS under basal conditions. It also increased insulin granule docking adhesion length and countered the inhibitory effects of TNF‐α on adhesion and actin remodeling at the β‐cell surface, resulting in preserved GSIS. DECORIN protected from cell death in sorted β‐cells and islets challenged with TNF‐α alone or TNF‐α + cytomix. Interestingly, DECORIN increased both insulin content and secretion in human islets from T2D individuals. Additionally, DECORIN treatment reversed the impaired gene expression caused by T2D and enhanced the expression of genes essential for islet function and metabolism.

Conclusion

Collectively, we have shown that DECORIN had a beneficial effect on human islets, protecting them from inflammation‐induced cell death. In T2D islets, DECORIN restores islet function and reverses the expression of T2D‐associated genes. Based on our data, we propose that DECORIN is a promising therapeutic target for diabetes‐associated inflammation and diabetes itself.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DecorinDiabetes Mellitus, Type 2Insulin-Secreting CellsInflammationIslets of LangerhansHumansAnimalsRatsMaleInsulinCells, CulturedCytokinesMyokines

Stichwörter der Autor:innen

DECORINinflammationinsulin secretioninsulin signaling pathwaymyokinessurvival

Substanzen

DecorinInsulinDCN protein, humanCytokinesMyokines

Autor:innen und Institutionen

  • UR Diabète et Thérapeutiques, Centre européen d'étude du Diabète, Université de Strasbourg, Strasbourg, France.
  • CarMeN Laboratory, Inserm U1060, INRAE UMR1397, Univ-Lyon, Université Claude Bernard Lyon-1, Lyon, France.
  • ILONOV, Boulevard René Leriche, Strasbourg, France.
  • Department of Cell Physiology and Metabolism, Centre Médical Universitaire, University of Geneva, Geneva, Switzerland.
  • Bioscience Metabolism, Research and Early Development, Cardiovascular, Renal and Metabolic (CVRM), BioPharmaceuticals R&D, Gothenburg, Sweden.
  • Department of Human Nutrition, Foods, and Exercise, Virginia Tech, Blacksburg, Virginia, USA.

ORCID-Profile: Karim Bouzakri

Förderung

  • Centre Europeen d'Etude du Diabete

Zitieren

APA

Langlois, A., Cherfan, J., Meugnier, E., Rida, A., Arous, C., Peronet, C., Hamdard, H., Zarrouki, B., Wehrle-Haller, B., Pinget, M., Craige, S. M., & Bouzakri, K. (2025). DECORIN , a triceps‐derived myokine, protects sorted β‐cells and human islets against chronic inflammation associated with type 2 diabetes. Acta Physiologica, 241(2). https://doi.org/10.1111/apha.14267

Vancouver

Langlois A, Cherfan J, Meugnier E, Rida A, Arous C, Peronet C, et al. DECORIN , a triceps‐derived myokine, protects sorted β‐cells and human islets against chronic inflammation associated with type 2 diabetes. Acta Physiologica. 2025;241(2). doi:10.1111/apha.14267

BibTeX
@article{Langlois2025,
  author = {Langlois, Allan and Cherfan, Julien and Meugnier, Emmanuelle and Rida, Ahmad and Arous, Caroline and Peronet, Claude and Hamdard, Harzo and Zarrouki, Bader and Wehrle-Haller, Bernhard and Pinget, Michel and Craige, Siobhan M and Bouzakri, Karim},
  title = {DECORIN , a triceps‐derived myokine, protects sorted β‐cells and human islets against chronic inflammation associated with type 2 diabetes},
  journal = {Acta Physiologica},
  year = {2025},
  volume = {241},
  number = {2},
  doi = {10.1111/apha.14267}
}
Kostenlos starten →